3
Clinical Trials associated with Mesenchymal Stem Cell Therapy(Hospital Clínic de Barcelona)A PHASE II, DOUBLE-BLIND, CONTROLLED, PARALLEL-ARM TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INFUSION OF ALLOGENIC MESENCHYMAL STEM CELLS IN LUPUS NEPHRITIS (LN) - ALLOGENIC MESENCHYMAL STEM CELLS IN NEPHRITIS LUPUS
Start Date20 Sep 2017 |
Sponsor / Collaborator- |
Therapeutic Effects of Allogenic Mesenchymal Stem Cells in Cirrhotic Patients With Acute-on-chronic Liver Failure. A Double-blind Randomized Placebo-controlled Trial
Double-blind placebo randomized controlled trial evaluating the clinical efficacy of allogenic bone marrow derived mesenchymal stem cells in cirrhotic patients with acute-on-chronic liver failure
Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
Bone marrow MSCs will be isolated from allogenic donors, expanded under hypoxic conditions using medium containing no serum or animal-derived reagents, and applies for Phase Ⅰ/Ⅱ study in treating 18 recipients with ischemic limb diseases.
100 Clinical Results associated with Mesenchymal Stem Cell Therapy(Hospital Clínic de Barcelona)
100 Translational Medicine associated with Mesenchymal Stem Cell Therapy(Hospital Clínic de Barcelona)
100 Patents (Medical) associated with Mesenchymal Stem Cell Therapy(Hospital Clínic de Barcelona)
100 Deals associated with Mesenchymal Stem Cell Therapy(Hospital Clínic de Barcelona)